HUTCHMED Completes FDA Submission for High-Potential Colorectal Cancer Drug | BioSpace
HUTCHMED has completed the rolling submission of its New Drug Application to the FDA for fruquintinib, its candidate for refractor metastatic colorectal cancer.
HUTCHMED has completed the rolling submission of its New Drug Application to the FDA for fruquintinib, its candidate for refractor metastatic colorectal cancer.
Ascites are abnormal pockets of fluid that develop in the abdomen. We spoke to gynecologic oncologist Travis Sims, M.D., to learn more about this late-stage…
HOUSTON ― Cancer survivors and tennis legends Chris Evert and Martina Navratilova participated in a fireside-style chat on Wednesday, May 1 at The University of…
Antibody-drug conjugates are a new type of cancer therapy that deliver cancer-killing medicine to cancer cells, avoiding healthy cells along the way.
For people with no family history of colon cancer or other risk factors Swedish researchers found that screening every 15 years was still protective.
How long does it take for chemotherapy to start shrinking a tumor? Head and neck specialist and thoracic medical oncologist Janet Tu, M.D., weighs in.
Nodular melanoma is a type of skin cancer that can mimic benign conditions, including blood blisters and acne. So, how do you know when to…
Experiencing guilt after cancer treatment may sound unexpected, but it’s actually quite common. Clinical psychologist Catherine Powers, Ph.D., and senior social work counselor Kendolyn Shankle…
Researchers uncover lung adenocarcinoma’s early roots, tracing the cancer back to a specific cell type. These insights offer new hope for detection and prevention.
Did you know that drinking alcohol can affect your cancer risk, lead to long-term health issues and impact your microbiome, sleep and brain function? Our…
Dr. Trisha Amboree explains the findings of the research and how it can help mitigate health disparities.